Please find enclosed herewith Intimation for closure of trading window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Genomic Valley Biotech Ltd has informed the stock exchanges that its trading window will be closed starting October 1, 2025. The closure is in line with SEBI's Insider Trading Regulations and applies to all directors, employees, key managerial personnel, designated persons, and their immediate relatives. The window will reopen 48 hours after the company announces its unaudited financial results for the quarter and half year ended September 30, 2025. This is a routine compliance filing ahead of the upcoming results announcement.
This is a standard regulatory disclosure with no direct impact on shareholders. It simply prevents insiders from trading in the stock until Q2/H1 FY26 results are published, signaling that the results announcement is likely due soon.